Skip to content

Aminolevulinic Acid

DRUG20 trials

Sponsors

Kinouchi Kenichiro, Miyake Makito, Roswell Park Cancer Institute, The Cleveland Clinic, Advocate Hospital System

Conditions

Actinic KeratosesActinic KeratosisAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed Glioma

Early Phase 1

Phase 1

Phase 2

Photodynamic Therapy in Treating Patients With Skin Cancer
CompletedNCT00002975
Roswell Park Cancer InstituteNon-melanomatous Skin Cancer, Precancerous Condition
Start: 1997-02-28End: 2010-04-30Updated: 2013-10-10
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
CompletedNCT00752323
Andrew Sloan, MDBrain and Central Nervous System Tumors
Start: 2009-12-08End: 2018-10-14Updated: 2021-09-17
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
TerminatedNCT00865878
DUSA Pharmaceuticals, Inc.Actinic Keratoses, Skin Neoplasms
Start: 2009-05-31End: 2011-09-30Updated: 2011-10-21
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
CompletedNCT00961090
Matthew R QuigleyGlioblastoma
Start: 2009-09-30End: 2015-04-23Updated: 2019-04-12
A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
TerminatedNCT01351519
MultiCare Health System Research InstituteAstrocytoma, Glioblastoma, Glioblastoma Multiforme +2
Start: 2011-05-31End: 2015-01-31Updated: 2016-03-17
Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
TerminatedNCT01575275
Michael Vogelbaum, MD, PhDAdult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma +1
Start: 2012-05-31End: 2014-08-31Updated: 2018-07-31
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
CompletedNCT02239679
DUSA Pharmaceuticals, Inc.Actinic Keratosis
Start: 2014-09-30End: 2016-09-30Updated: 2018-08-24
Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II
TerminatedNCT02728388
Donald BaselNEUROFIBROMATOSIS 1
Start: 2016-09-16End: 2026-03-28Target: 30Updated: 2026-07-10
A prospective study of oral 5-AMinolevulinic acid for preventing adverse events in patients with localized prostate cancer undergoing low-dose rate BrachythERapy
Active, not recruitingJPRN-jRCTs051190077
Miyake MakitoLocalized prostate cancer prostate, neoplasm
Start: 2019-12-05Target: 50Updated: 2026-06-29

Phase 4

Unknown Phase

Related Papers